[Synthesis of Schizandrin C analogs (author's transl)].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J X Chen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In this study, semen samples from fertile and unexplained infertile men were explored for relationships between seminal plasma immunosuppressive factors (SPIFs), semen pH, liquefaction duration and infection of ureaplasma urealyticum (Uu). SPIFs activity was measured by way of counteracting complement. PH was detected by exact pH test paper. Liquefaction duration was observed at 37 degrees C. The results showed that Uu infection ratios of semen samples with abnormal SPIFs, pH or liquefaction duration were markedly higher than those of normal semen samples. It is suggested that Uu infection decreases the level of SPIFs, changes the pH in semen and prolongs the semen liquefaction so as to cause spermatic quality decline. The enhancement of SPIFs level may change the male body against Uu infection.
This study investigated the association among male infertility, infection of Ureaplasma urealyticum (Uu), and microelements in semen fluid. Semen analysis and cultivation of Uu are carried out to 165 samples of semen fluid. Then the contents of microelements, such as Cu, Fe, Se, Cd, Mn, and Zn, in the samples are measured respectively by an Inductively Coupled Plasma Quantometer (ICP). The contents of Fe, Se, and Zn in seminal plasma of the normal spermatic quality group are obviously higher than those of the poor spermatic quality group (p<.05), while the content of Cd in seminal plasma of the normal spermatic quality group is obviously lower than that of the poor spermatic quality group (p<.05), and the contents of Cu and Mn show no difference. The contents of Zn, Se, and Cu in seminal plasma infected with Uu are markedly lower than those of seminal plasma not infected with Uu (p<.05), while the content of Cd in seminal plasma infected with Uu is obviously higher than that in samples not infected with Uu, and the contents of Fe and Mn show no statistic difference. The contents of Zn and Se in seminal plasma of the poor spermatic qualitative semen that were infected with Uu are obviously lower than those of seminal plasma not infected with Uu (p<.05), while the content of Cd in seminal plasma of the poor spermatic qualitative semen with Uu infection is markedly higher than that of the normal seminal plasma (p<.05). Uu infection leads to the decrease of the contents of Zn and Se in semen fluid, and therefore causes spermatic quality decline. Lack of Fe or overdose of Cd may also contribute to spermatic quality decline.
UNLABELLED: The purpose of this study was to evaluate the usefulness of 99mTc-MIBI scintinammography for the detection of breast cancer. METHODS: Sixty-one consecutive patients referred for a suspicions breast lesion on clinical examination were studied with 99mTc-MIBI scintimammography. There were 60 female patients and 1 male patient with 63 pulpable breast abnormalities. Each patient received 20mCi 99mTc-MIBI intravenously. Ten and 120 minutes postinjection, three planar views, right and left lateral prone and anterior supine thoracic views, were obtained. The patient underwent surgery within one week and the final diagnostic results (histopathology) were obtained. RESULTS: Thirty-two of 63 abnormalities of breast were pathologically confirmed breast cancer, and 31 were benign lesions. In the group of patients studied, the sensitivity of 99mTc-MIBI scintimammography was 78.1% (25 true-positive, 7 false-negative) and the specificity was 90.3% (28 true-negative, 3 false positive). The positive predictive value was 89.3%, the negative predictive value was 80.0%, the positive likelihood ratio was 8.1, the negative likelihood ratio was 0.2. CONCLUSION: This study showed the high diagnostic accuracy of 99mTc-MIBI scintimammography in detecting breast cancer. 99mTc-MIBI scintimammography can be used as an assistant method to non-invasively assess breast cancer invasiveness before surgery.